These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12654540)

  • 1. Inducing apoptosis: mind the natural killer cells.
    Gurwitz D; Gurwitz ML
    Drug Discov Today; 2003 Apr; 8(7):292. PubMed ID: 12654540
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation.
    Zhu D; Corral LG; Fleming YW; Stein B
    Cancer Immunol Immunother; 2008 Dec; 57(12):1849-59. PubMed ID: 18392823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heterogeneity of the interaction between cancer chemotherapeutic agents and host resistance mechanisms.
    Spreafico F
    Recent Results Cancer Res; 1980; 75():200-6. PubMed ID: 6453410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced apoptosis of natural killer cells and cytotoxic T lymphocytes.
    Migliorati G; Pagliacci C; Moraca R; Crocicchio F; Nicoletti I; Riccardi C
    Pharmacol Res; 1992 Sep; 26 Suppl 2():26-7. PubMed ID: 1409314
    [No Abstract]   [Full Text] [Related]  

  • 6. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity.
    Lundqvist A; Abrams SI; Schrump DS; Alvarez G; Suffredini D; Berg M; Childs R
    Cancer Res; 2006 Jul; 66(14):7317-25. PubMed ID: 16849582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Tumor Medicine and Drug Targets.
    Liu W; Wang X; Zhu H; Duan Y
    Curr Top Med Chem; 2019; 19(17):1488-1489. PubMed ID: 31592750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of chemotherapy on natural killer (NK) activity and antibody-dependent cell-mediated cytotoxicity (ADCC) in carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M
    Nihon Ika Daigaku Zasshi; 1987 Feb; 54(1):40-53. PubMed ID: 3558739
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect(s) of rIL-2 modulation. I. The effects of chemotherapeutic/cytotoxic agents on human natural killer cells and lymphokine-activated killer cells.
    Ades EW; Hinson A
    J Immunopharmacol; 1986; 8(4):481-97. PubMed ID: 3492564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune system in the fight against cancer.
    Future Oncol; 2006 Feb; 2(1):11. PubMed ID: 16634135
    [No Abstract]   [Full Text] [Related]  

  • 11. The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.
    Le Garff-Tavernier M; Herbi L; de Romeuf C; Azar N; Roos-Weil D; Bonnemye P; Urbain R; Leblond V; Merle-Beral H; Vieillard V
    Haematologica; 2015 Apr; 100(4):e147-51. PubMed ID: 25552707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].
    Dong LF; Zhang YJ; Liu JS; Song SX; Hou J; Lu ZJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):458-62. PubMed ID: 16806008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.
    Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD
    Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of diethylstilbestrol diphosphate (DES-P) and alpha-interferon on natural killer cell activity in vitro].
    Ueno M; Marumo K; Muraki J; Baba S; Murai M; Tazaki H; Yamamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1707-16. PubMed ID: 3444162
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.
    Siew YY; Neo SY; Yew HC; Lim SW; Ng YC; Lew SM; Seetoh WG; Seow SV; Koh HL
    Int Immunol; 2015 Dec; 27(12):621-32. PubMed ID: 26138671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of orally administered glycogen on anti-tumor activity and natural killer cell activity in mice.
    Kakutani R; Adachi Y; Kajiura H; Takata H; Kuriki T; Ohno N
    Int Immunopharmacol; 2012 Jan; 12(1):80-7. PubMed ID: 22080051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon: facts and hopes. I. Properties of interferon].
    Dmoszyńska-Giannopoulou A; Rupniewska ZM
    Pol Arch Med Wewn; 1981 Oct; 66(4):303-6. PubMed ID: 6174953
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural born killers: NK cells drafted into the cancer fight.
    O'Hanlon LH
    J Natl Cancer Inst; 2004 May; 96(9):651-3. PubMed ID: 15126597
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of thalidomide and its analogues: implications for anticancer therapy.
    Teo SK
    AAPS J; 2005 Mar; 7(1):E14-9. PubMed ID: 16146335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
    Iwata S; Yano S; Ito Y; Ushijima Y; Gotoh K; Kawada J; Fujiwara S; Sugimoto K; Isobe Y; Nishiyama Y; Kimura H
    Int J Cancer; 2011 Nov; 129(9):2263-73. PubMed ID: 21170988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.